Cargando…
Aspirin use and endometrial cancer risk: a meta-analysis and systematic review
BACKGROUND: The use of aspirin has been linked to a reduced risk of cancer at several sites, such as the breast, prostate, and colorectum. However, the evidence for this chemopreventive effect from aspirin use on endometrial cancer is conflicting, and whether an association exists is an open questio...
Autores principales: | Wang, Yang, Zhao, Junda, Chen, Xing, Zhang, Feifei, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210134/ https://www.ncbi.nlm.nih.gov/pubmed/32395505 http://dx.doi.org/10.21037/atm.2020.03.125 |
Ejemplares similares
-
Aspirin and endometrial cancer risk
por: Brasky, Theodore M., et al.
Publicado: (2016) -
Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2018) -
Frequency-Risk and Duration-Risk Relationships between Aspirin Use and Gastric Cancer: A Systematic Review and Meta-Analysis
por: Ye, Xiaohua, et al.
Publicado: (2013) -
Dietary Fiber Intake and Endometrial Cancer Risk: A Systematic Review and Meta-Analysis
por: Chen, Kangning, et al.
Publicado: (2018) -
Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
por: Chu, Danxia, et al.
Publicado: (2018)